Fact checked by Nick Blackmer Karen Peterson was diagnosed with stage 1 triple-negative breast cancer in 2015. After undergoing three months of chemotherapy with difficult side effects, she made the ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Gain insights to de-risk and accelerate your trials. Explore with us the value of integrating precision medicine into your clinical trials — from patient selection to operational efficiency.

Addressing Barriers to Equitable Inclusion in Clinical Trials, With Dr. Miguel Regueiro, Dr. Neilanjan Nandi, and Ms. Tina Aswani-Omprakash ...

The platform's patient-focused outreach is beneficial in navigating the complexities of evolving eligibility criteria for ...

Recently, alternative endpoints, including progression-free survival (PFS), have emerged as popular readouts for many phase 3 clinical trials. PFS indicates the time from diagnosis (or treatment ...

DENALI-1 is a multicenter phase 1/2 dose-escalation clinical study to evaluate the safety and efficacy of A2B395, an allogeneic logic-gated CAR T cell therapy, in participants with solid tumors that ...

While sitting in the Moores Cancer Center auditorium at UC San Diego Health for the 2025 Clinical Trials Patient Appreciation Day, I was surrounded by medical teams, colleagues, community members and ...

At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of an AA battery.

In the US Diabetes Prevention Program (DPP), a 3-year randomised clinical trial in 3234 adults with prediabetes, type 2 diabetes incidence was reduced by 58% with intensive lifestyle intervention (ILS ...

China’s NMPA is proposing to cut down the clinical trial review waiting period for novel medicines to 30 working days from the current 60.